| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,215 |
2,157 |
$191K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
5,651 |
4,367 |
$178K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,148 |
3,056 |
$173K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,539 |
1,537 |
$129K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
1,353 |
1,351 |
$113K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
1,073 |
1,067 |
$85K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
889 |
889 |
$81K |
| 90461 |
|
1,534 |
1,531 |
$58K |
| S0302 |
Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) |
5,422 |
5,411 |
$49K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
2,836 |
2,795 |
$31K |
| 96127 |
|
2,604 |
2,603 |
$27K |
| 99177 |
|
775 |
775 |
$18K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
628 |
622 |
$18K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
243 |
243 |
$17K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
2,137 |
2,128 |
$16K |
| 99188 |
|
567 |
564 |
$15K |
| 36416 |
|
892 |
886 |
$9K |
| 83655 |
|
614 |
614 |
$7K |
| 80061 |
Lipid panel |
343 |
340 |
$4K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
212 |
212 |
$4K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
65 |
64 |
$3K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
229 |
229 |
$3K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
78 |
77 |
$3K |
| 99050 |
|
100 |
100 |
$2K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
54 |
54 |
$1K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
54 |
54 |
$1K |
| 87081 |
|
177 |
176 |
$1K |
| 0071A |
|
30 |
30 |
$1K |
| 94760 |
|
508 |
489 |
$1K |
| 0001A |
|
27 |
27 |
$1K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
12 |
12 |
$1K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
38 |
38 |
$897.56 |
| 92587 |
|
39 |
39 |
$658.71 |
| 36415 |
Collection of venous blood by venipuncture |
234 |
230 |
$525.63 |
| 83718 |
|
61 |
61 |
$515.45 |
| 81003 |
|
208 |
204 |
$455.26 |
| 82465 |
|
61 |
61 |
$273.28 |
| 99173 |
|
12 |
12 |
$266.64 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
15 |
14 |
$228.90 |
| 99051 |
|
13 |
13 |
$215.28 |
| 99000 |
|
26 |
26 |
$26.00 |